ES2189462T3 - Derivados de acido aminometilcarboxilico. - Google Patents

Derivados de acido aminometilcarboxilico.

Info

Publication number
ES2189462T3
ES2189462T3 ES99939419T ES99939419T ES2189462T3 ES 2189462 T3 ES2189462 T3 ES 2189462T3 ES 99939419 T ES99939419 T ES 99939419T ES 99939419 T ES99939419 T ES 99939419T ES 2189462 T3 ES2189462 T3 ES 2189462T3
Authority
ES
Spain
Prior art keywords
alkyl
aryl
oxy
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99939419T
Other languages
English (en)
Inventor
Samuel George Gibson
David Robert Jaap
Simon Nicholas Thorn
Robert Gilfillan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2189462T3 publication Critical patent/ES2189462T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un derivado de ácido aminometilcarboxílico que tiene la fórmula general I **(Fórmula)** donde Z es (CH2)n, O, S, SO, SO2 o N-R5;+ n es 0, 1 o 2; X representa 1-3 sustituyentes seleccionados independientemente entre hidrógeno, halógeno, alquil(C1-C6)oxi, cicloalquil(C3-C6)oxi, aril(C6-C12)oxi, arilo C1-C6, tienilo, SR6, SOR6, SO2R6, NR6R6, NH2, NHCOR6, NHSO2R6, CN, COOR6 y alquilo C1-C4, opcionalmente sustituido con halógeno, arilo C6C12, alquil(C1-C6)oxi o aril(C6-C12)oxi; o 2 sustituyentes en posiciones adyacentes representan juntos un grupo arilo C5-C6 fusionado, un grupo cicloalquilo C5-C6 fusionado o O-(CH2)m-O; m es 1 o 2; Y representa 1-3 sustituyentes seleccionados independientemente entre hidrógeno, halógeno, alquil(C1C4)oxi, SR6, NR6R6 y alquilo C1-C4, opcionalmente sustituido con halógeno; R1 es COOR7 o CONR8R9; R2 y R6 son alquilo C1-C4; R3, R4 y R5 son independientemente hidrógeno o alquilo C1-C4; R7, R8 y R9 son independientemente hidrógeno, alquilo C1-C4, arilo C6-C12 o arilaquilo; o una sal farmacéuticamente aceptable del mismo.
ES99939419T 1998-07-31 1999-07-26 Derivados de acido aminometilcarboxilico. Expired - Lifetime ES2189462T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98306149 1998-07-31

Publications (1)

Publication Number Publication Date
ES2189462T3 true ES2189462T3 (es) 2003-07-01

Family

ID=8234975

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99939419T Expired - Lifetime ES2189462T3 (es) 1998-07-31 1999-07-26 Derivados de acido aminometilcarboxilico.

Country Status (28)

Country Link
US (1) US6410592B1 (es)
EP (1) EP1100769B1 (es)
JP (1) JP4290340B2 (es)
KR (1) KR100640031B1 (es)
CN (1) CN1191232C (es)
AR (1) AR049670A1 (es)
AT (1) ATE228995T1 (es)
AU (1) AU762759B2 (es)
BR (1) BR9912621A (es)
CA (1) CA2337041C (es)
CO (1) CO5080746A1 (es)
CZ (1) CZ301620B6 (es)
DE (1) DE69904335T2 (es)
DK (1) DK1100769T3 (es)
ES (1) ES2189462T3 (es)
HK (1) HK1035525A1 (es)
HU (1) HUP0102766A3 (es)
ID (1) ID26978A (es)
IL (1) IL140358A0 (es)
NO (1) NO327756B1 (es)
NZ (1) NZ509568A (es)
PL (1) PL198041B1 (es)
PT (1) PT1100769E (es)
RU (1) RU2225389C2 (es)
SK (1) SK286474B6 (es)
TR (1) TR200100270T2 (es)
TW (1) TW555757B (es)
WO (1) WO2000007978A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
DE102004030099A1 (de) * 2004-06-22 2006-01-12 Grünenthal GmbH Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren
MX2007008460A (es) * 2005-01-14 2007-07-25 Organon Nv Inhibidores de la reabsorcion de glicina para el tratamiento de dependencia a farmacos.
KR101381768B1 (ko) * 2006-01-06 2014-04-07 선오비온 파마슈티컬스 인코포레이티드 테트랄론-기재 모노아민 재흡수 저해제
WO2009059961A2 (en) * 2007-11-06 2009-05-14 N.V. Organon A method of hormone suppression in humans
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
EP2380595A1 (en) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
US8883839B2 (en) * 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) * 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
JP2014521682A (ja) * 2011-08-05 2014-08-28 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー アミノクロマン、アミノチオクロマンおよびアミノ−１，２，３，４−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用
KR102021162B1 (ko) 2011-11-01 2019-09-11 메르크 파텐트 게엠베하 유기 전계발광 소자
KR102310368B1 (ko) 2011-11-17 2021-10-07 메르크 파텐트 게엠베하 스피로디히드로아크리딘 유도체 및 이의 유기 전계발광 소자용 재료로서의 용도
WO2013072520A1 (en) 2011-11-18 2013-05-23 AbbVie Deutschland GmbH & Co. KG N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
EP2828266B1 (de) 2012-03-23 2017-10-18 Merck Patent GmbH 9,9'-spirobixanthenderivate für elektrolumineszenzvorrichtungen
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
EP3057958B1 (en) 2013-10-17 2019-05-01 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
CA2924689A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CN104844471B (zh) * 2015-04-21 2017-05-03 苏州远智医药科技有限公司 一种作为dor受体拮抗剂的化合物
US10226442B2 (en) 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof
WO2019058393A1 (en) 2017-09-22 2019-03-28 Jubilant Biosys Limited HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD
SG11202003463XA (en) 2017-10-18 2020-05-28 Jubilant Epipad LLC Imidazo-pyridine compounds as pad inhibitors
CN111386265A (zh) 2017-11-06 2020-07-07 朱比连特普罗德尔有限责任公司 作为pd1/pd-l1活化的抑制剂的嘧啶衍生物
MX2020005363A (es) 2017-11-24 2020-10-01 Jubilant Episcribe Llc Compuestos heterociclicos como inhibidores de prmt5.
EP3765453A1 (en) 2018-03-13 2021-01-20 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
CN110003160B (zh) * 2019-05-14 2022-10-11 贵州中医药大学 一种蛇床子素腙类/酰腙类/磺酰腙类衍生物及其制备方法以及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5657157A (en) * 1995-06-23 1997-08-12 Sdl, Inc. Semiconductor optical amplifying media with reduced self-focusing
WO1997012870A1 (en) * 1995-09-29 1997-04-10 Glaxo Wellcome S.P.A. Tetrahydroquinolines as nmda antagonists
CA2255727A1 (en) * 1996-05-31 1997-12-04 Trophix Pharmaceuticals, Inc. Pharmaceutical for treating of neurological and neuropsychiatric disorders
EP1014966B1 (en) 1996-05-31 2006-08-02 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders

Also Published As

Publication number Publication date
AU5372499A (en) 2000-02-28
NO327756B1 (no) 2009-09-14
KR100640031B1 (ko) 2006-10-31
JP2002522412A (ja) 2002-07-23
WO2000007978A1 (en) 2000-02-17
CZ2001398A3 (cs) 2001-07-11
DK1100769T3 (da) 2003-03-24
SK286474B6 (sk) 2008-11-06
DE69904335D1 (en) 2003-01-16
PL198041B1 (pl) 2008-05-30
CN1191232C (zh) 2005-03-02
RU2225389C2 (ru) 2004-03-10
AU762759B2 (en) 2003-07-03
HK1035525A1 (en) 2001-11-30
CA2337041A1 (en) 2000-02-17
HUP0102766A3 (en) 2002-11-28
NZ509568A (en) 2003-05-30
EP1100769B1 (en) 2002-12-04
BR9912621A (pt) 2001-04-24
AR049670A1 (es) 2006-08-30
PT1100769E (pt) 2003-04-30
NO20010514D0 (no) 2001-01-30
PL345794A1 (en) 2002-01-02
CO5080746A1 (es) 2001-09-25
CA2337041C (en) 2009-05-26
JP4290340B2 (ja) 2009-07-01
HUP0102766A2 (hu) 2001-12-28
EP1100769A1 (en) 2001-05-23
US6410592B1 (en) 2002-06-25
DE69904335T2 (de) 2003-10-09
SK1492001A3 (en) 2001-08-06
KR20010072137A (ko) 2001-07-31
IL140358A0 (en) 2002-02-10
NO20010514L (no) 2001-01-30
ATE228995T1 (de) 2002-12-15
ID26978A (id) 2001-02-22
TR200100270T2 (tr) 2001-05-21
CN1309631A (zh) 2001-08-22
CZ301620B6 (cs) 2010-05-05
TW555757B (en) 2003-10-01

Similar Documents

Publication Publication Date Title
ES2189462T3 (es) Derivados de acido aminometilcarboxilico.
EP0073143A3 (en) Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
DE69315079D1 (de) Beta-aminoalkyl und beta-n-peptidylaminoalkylborsäure
ES2188184T3 (es) Compuestos de beta-carbolinas.
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
AR012781A1 (es) Alfa-cetoamida inhibidores de 20s proteosoma.
DE69619711D1 (de) Retinoid-potenzierende verbindungen
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
AR006890A1 (es) Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticos
DK0795334T3 (da) Nye prodrugs til behandling af tumorer og betændelsessygdomme
ES2260933T3 (es) Derivados del acido de tiazolina.
DE3561741D1 (de) Triphenedioxazine vinylsulfonyl dyestuffs
CO5261618A1 (es) Derivados de espiro [2h-1-benzopiran-2,4 -piperidina]
HUP0105105A2 (hu) Gyulladásgátló hatású makrolidok és ezeket tartalmazó gyógyszerkészítmények
DK0958280T3 (da) Arylpiperidinopropanol- og arylpiperazinopropanolderivater og farmaceutiske midler der indeholder disse
ATE182589T1 (de) Verfahren zur herstellung von benzyliden- derivaten
DE59409595D1 (de) Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
ATE299861T1 (de) Ppar-(gamma) agonisten zur behandlung von type ii diabetes
ES2001944A6 (es) Procedimiento de obtencion de derivados de xantina con actividad broncodilatadora y antiasmatica.
DK0953563T3 (da) Fremgangsmåde til fremstilling af depsipeptidderivater samt hidtil ukendte intermediater derfor
AU567867B2 (en) 5(e)-13,14,18,18,19,19-hexahydro-6a-carbaprostaglandin 12 derivatives
ATE204582T1 (de) Von neurokininen abgeleitete pseudopeptide, verfahren für ihre herstellung und sie enthaltende pharmazeutische zubereitungen
ES2185360T3 (es) Derivados de 22s-hidroxicolesta-8,14-dieno con actividad reguladora de la meiosis.
NO20010332D0 (no) Nye 6-deoksyerytromycinderivater, metoder for fremstilling av disse, og anvendelse som medisiner